DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01777 P3 ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL SARS-CoV-2 32482145
DRAVPe01778 Alisporivir, Debio-025 XxXVXAaXXXX SARS-CoV-2 32376613,32568027
DRAVPe01779 Plitidepsin, Aplidine PxTXXLPX SARS-CoV-2 35231500,33495306
DRAVPe01802 FBP RGAHIKGRWKSRCHRF Influenza A virus, Influenza B virus, SARS-CoV-2 35259078
DRAVPe01821 BPIP LLMVNEATRFQTVSGFV SARS-CoV-2 35896605
DRAVPe01865 PIH CGGGGGSLTEINTELLDLEYEMKKLEEVVKKLEESYIDLKEL MERS-CoV 31099550
DRAVPe01948 Bomidin MGRFKRFRKKFKKLFKKLS DENV, HSV,SARS-CoV-2 35663971
DRAVPe01977 SARS-CoV S (668–679), SP-10 STSQKSIVAYTM SARS-CoV 16337697
DRAVPe01978 SARS-CoV S (192-203), SP-4 GFLYVYKGYQPI SARS-CoV 16337697
DRAVPe01979 SARS-CoV S (483-494), SP-8 FYTTTGIGYQPY SARS-CoV 16337697
DRAVPe01981 Peptide1(ACE2 (21-43)[N13Q,A16V,D18E,L19I,F20Y,Y21W]) IEEQAKTFLDKFQHEVEEIYWQS SARS-CoV-2 34328726
DRAVPe01982 Peptide2 QDKHEEDYQMYNKGDKED SARS-CoV-2 34328726
DRAVPe01983 Peptide3 DKFNHEAEDLFYQSSLASWNYNT SARS-CoV-2 34328726
DRAVPe01984 Peptide4 IDENARSYIDKFQHDAEEMWYQ SARS-CoV-2 34328726
DRAVPe01985 Peptide5 IYALLENAEDYNLVN SARS-CoV-2 34328726
DRAVPe01986 Peptide6 SRDKHEEHEKENDRGQ SARS-CoV-2 34328726
First 2 3 4 5 6 7 8 Last